Donate

Individual research projects

Our world-class research is focused entirely on breast cancer. Right now, we’re funding almost £30 million worth of ground-breaking research projects.

Our research projects

A photo of Professor Ellen Copson

A trial investigating the link between muscle loss and the severity of chemo side effects in secondary breast cancer

Professor Ellen Copson

Image Professor Richard Clarkson

Finding ways to make triple negative breast cancer more sensitive to chemotherapy

Professor Richard Clarkson

Professor Matthew Smalley and Giusy Tornillo posing for photos in a laboratory.

Testing a tracer to measure the response of secondary tumours in the bone to treatment

Professor Gary Cook

Professor Matthew Smalley and Giusy Tornillo posing for photos in a laboratory.

Investigating prevention strategies for altered BRCA1-related breast cancers

Dr Sacha Howell

Understanding the impact of COVID-19 on breast cancer services in Northern Ireland

Professor Anna Gavin

Dr Ali Roghanian in the research lab standing in front of equipment

Understanding the communication between cancer cells and immune cells

Dr Ali Roghanian

Dr Nick Orr

Understanding how some genetic changes lead to breast cancer in men and women

Dr Nick Orr

Dr Hamid Ali in a research lab

Identifying who would benefit most from immunotherapy

Dr Hamid Ali

Combining drugs to improve the effectiveness of chemotherapy

Dr Thomas A Hughes

Rachael, a woman with shoulder length hair and brown eyes, Alejandro, with short dark hair, and dark framed glasses, a white BCN lab coat, smiling for portraits in a white lab coat, with the laboratory in the background.

The Catalyst Programme: Understanding the role of SF3B1 in breast cancer

Dr Rachael Natrajan

Professor Greg Hannon and his team of researchers. They are all sat in a brightly lit room in front of a window.

The Catalyst Programme: Understanding how breast cancer becomes resistant to treatments

Professor Greg Hannon

Professor Leonie Young

The Catalyst Programme: Testing if PARP inhibitors could be used to treat secondary breast cancer in the brain

Professor Leonie Young